TrialCancer immunology, immunotherapy : CII2013

Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).

Antonia Busse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.